PACLITAXEL
- Product NDC
- 67457-937
- 11-digit product format
- 674570937
- Labeler code
- 67457
- Product ID
- 67457-937_2e325564-59ba-4a16-86b4-5535cd4b53f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PACLITAXEL
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA217877
- Marketing category
- ANDA
- Marketing start
- 2025-10-09
- Substance
- PACLITAXEL
- Active strength
- 100 mg/20mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PACLITAXEL
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PACLITAXEL | 100 mg/20mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | P88XT4IS4D |
| Rxcui | 583214 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67457-937-50 | PACLITAXEL | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67457-937-50 | 67457093750 | 20 mL in 1 VIAL (67457-937-50) | 20 ml | 2025-10-09 | No | No | Historical |